Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose‐ranging study

AIMS: The aims of the present study were to investigate the maternal, fetal and neonatal safety and tolerability, pharmacodynamics and pharmacokinetics of intravenous (IV) retosiban in pregnant women with spontaneous preterm labour (PTL) between 34(0/7) and 35(6/7) weeks' gestation. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Thornton, Steven, Valenzuela, Guillermo, Baidoo, Charlotte, Fossler, Michael J., Montague, Timothy H., Clayton, Linda, Powell, Marcy, Snidow, Jerry, Stier, Brendt, Soergel, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Drugs in Pregnancy and Lactation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595955/
https://www.ncbi.nlm.nih.gov/pubmed/28556962
http://dx.doi.org/10.1111/bcp.13336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595955/
https://www.ncbi.nlm.nih.gov/pubmed/28556962
http://dx.doi.org/10.1111/bcp.13336

Ejemplares similares